» Articles » PMID: 7649275

Differential Expression of Voltage-activated Na+ Currents in Two Prostatic Tumour Cell Lines: Contribution to Invasiveness in Vitro

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1995 Aug 7
PMID 7649275
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

The voltage-gated ionic currents of two rodent prostatic cancer cell lines were investigated using the whole-cell patch clamp technique. The highly metastatic Mat-Ly-Lu cells expressed a transient, inward Na+ current (blocked by 600 nM tetrodotoxin), which was not found in any of the weakly metastatic AT-2 cells. Although both cell lines expressed a sustained, outward K+ current, this occurred at a significantly higher density in the AT-2 than in the Mat-Ly-Lu cells. Incubation of the Mat-Ly-Lu cell line with 600 nM tetrodotoxin significantly reduced the invasive capacity of the cells in vitro. Under identical conditions, tetrodotoxin had no effect on the invasiveness of the AT-2 cells.

Citing Articles

Electrical excitability of cancer cells-CELEX model updated.

Djamgoz M Cancer Metastasis Rev. 2024; 43(4):1579-1591.

PMID: 38976181 PMC: 11554705. DOI: 10.1007/s10555-024-10195-6.


The role of lidocaine in cancer progression and patient survival.

Chida K, Kanazawa H, Kinoshita H, Roy A, Hakamada K, Takabe K Pharmacol Ther. 2024; 259:108654.

PMID: 38701900 PMC: 11162934. DOI: 10.1016/j.pharmthera.2024.108654.


Anti-Algics in the Therapeutic Response of Breast and Urological Cancers.

Matos A, Lorigo J, Marques I, Abrantes A, Joia-Gomes M, Sa-Couto P Int J Mol Sci. 2024; 25(1).

PMID: 38203640 PMC: 10778606. DOI: 10.3390/ijms25010468.


Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane.

Rizaner N, Fraser S, Gul I, Purut E, Djamgoz M, Altun S J Membr Biol. 2024; 257(1-2):17-24.

PMID: 38165418 DOI: 10.1007/s00232-023-00302-z.


Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets.

Sanchez-Sandoval A, Hernandez-Plata E, Gomora J Front Pharmacol. 2023; 14:1206136.

PMID: 37456756 PMC: 10348687. DOI: 10.3389/fphar.2023.1206136.